Bond Johnson & Johnson Inc. 1.125% ( US478160BR44 ) in USD
| Issuer | Johnson & Johnson Inc. |
| Market price | 99.988 % ▼ |
| Country | United States
|
| ISIN code |
US478160BR44 ( in USD )
|
| Interest rate | 1.125% per year ( payment 2 times a year) |
| Maturity | 01/03/2019 - Bond has expired |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | 2 000 USD |
| Total amount | 700 000 000 USD |
| Cusip | 478160BR4 |
| Detailed description |
Johnson & Johnson is a multinational corporation that manufactures and sells a wide range of healthcare products, including pharmaceuticals, medical devices, and consumer health products. This article details the characteristics and lifecycle completion of a specific fixed-income instrument: a bond issued by Johnson & Johnson, identified by ISIN US478160BR44 and CUSIP 478160BR4. Johnson & Johnson, a globally recognized American multinational corporation with extensive operations across pharmaceuticals, medical devices, and consumer health products, consistently accesses capital markets to support its significant global financing requirements. This particular bond, originating from the United States and denominated in US Dollars (USD), represented a total issuance size of $700,000,000. It was structured with an annual interest rate of 1.125%, with interest payments distributed semi-annually, and featured a minimum purchase denomination of $2,000. Prior to its expiration, the bond?s market price was observed at 99.988% of par. A key characteristic of this instrument's current status is that it successfully reached its scheduled maturity date of March 1, 2019, and has since been fully redeemed by the issuer, thereby concluding its term and repaying bondholders. |
Français
Italiano
United States